183 results about "Preventative treatment" patented technology

Embodiments are directed to microneedle array devices for intradermal and/or transdermal interaction with the body of patient to provide therapeutic, diagnostic or preventative treatment wherein portions of the devices may be formed by multi-layer, multi-material electrochemical fabrication methods and wherein individual microneedles may include valve elements or other elements for controlling interaction (e.g. fluid flow). In some embodiments needles are retractable and extendable from a surface of the device. In some embodiments, interaction occurs automatically with movement across the skin of the patient while in other embodiments interaction is controlled by an operator (e.g. doctor, nurse, technician, or patient).

An implantable medical device is disclosed comprising a high-density lipoprotein (HDL), recombinant HDL, high-density lipoprotein mimics (HDLm), or a combination thereof. Method are also disclosed for local and systemic administration HDL, recombinant HDL or HDLm for the prevention, treatment, or amelioration of a vascular disorder, disease or occlusion such as restenosis or vulnerable plaque.

The present invention provides extended release compositions comprising neuregulin for preventing, treating or delaying various diseases or disorders. The present invention also provides methods for preventing, treating or delaying various diseases or disorders by extended release of neuregulin.

The invention provides noodles with various tastes and long-acting preventive and curative effects on cold, and the preparation method thereof. The invention solves the problems of the noodles, such as single taste and no disease preventive effect. The noodles comprise, by weight parts: 90-100 parts of flour, 1-2.5 parts of flavoring agents and 10-15 parts of medicinal juice. The preparation method of the noodles comprises the steps of: mixing 90-100 parts of the flour, 1-2.5 parts of the flavoring agents and 10-15 parts of the medicinal juice by weight parts, stirring to form the dough and pressing into the noodles. The original drug effect of the medicinal juice is retained. On one hand, the drug durability is reinforced and the drug release time is prolonged due to the protein in the noodles. On the other hand, the drug taste is overwhelmed by using the flavoring agent. The noodles have the advantages of various tastes, abundant nutrition, long shelf life, and convenient transportation and processing, and stimulate the appetite.

It is intended to provide preventives/remedies for graft-versus-host disease and/or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis. The above object can be achieved by preventives/remedies for graft-versus-host disease and/or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis characterized by containing a specific compound having a CCR (CC chemokine receptor) antagonism.

The present invention provides pharmaceutical compositions in the form of relatively high molecular weight biocompatible polymers such as polyethylene glycol, optionally supplemented with a protective polymer such ad dextran and/or essential pathogen nutrients such as L-glutantine. Also provided are methods for preventing or treating gut-derived sepsis attributable to intestinal pathogens such as Pseudomonas aeruginosa by administering high molecular weight polyethylene glycol as well as methods for monitoring the administration of high molecular weight polyethylene glycol, such as in methods of preventing, ameliorating or treating microbe-induced epithelial disorders, as exemplified by gut-derived sepsis. Frequently, gut-derived sepsis arises as a complication in mammals recovering from surgical intervention or suffering from a disease or disorder, providing indications of suitable animals to receive preventative treatment. Finally, the invention provides a composition comprising infant formula and polyethylene glycol and methods for using that composition.

The invention relates to the field of veterinary medicines, in particular to a Chinese medicinal composition, a Chinese medicinal preparation and a feed for treating and/or preventing respiratory system diseases of livestock. The Chinese medicinal composition is prepared from gypsum, honeysuckle, indigowoad root, baical skullcap root, weeping forsythia, common anemarrhena rhizome, platycodon root and liquoric root. The Chinese medicinal composition, the Chinese medicinal preparation and the feed have the effects of freeing lung, relieving asthma, reducing phlegm, relieving cough, clearing heat and detoxifying, resisting bacteria, diminishing inflammation and improving the immunity of organisms, have a simple production process, are low in cost, do not have toxic or side effects, and can prevent and control various respiratory system diseases of the livestock, enhance the resistance of the organisms, avoid livestock diseases and improve the yield of livestock products.

A system and method is disclosed whereby a customer involved in a transaction is offered a benefit to be applied to the transaction in exchange for undertaking or agreeing to undertake some form of preventative treatment. The transaction may be a purchase of goods or services occurring, for example, over the Internet. In one embodiment, the customer may select an option whereby a third party, such as an insurer of the customer, will provide payment for at least part of the transaction, in exchange for the customer undergoing a preventative treatment. The preventative treatment may include a health treatment screening or test. The payment provided may be determined from an expected future savings in insuring the customer if the preventative treatment is undertaken. Payment may also be conditioned upon the customer's agreement to continue his or her insurance coverage with the insurer or to confirm that the preventative treatment was performed. In certain embodiments, the insurer may place a hold against a financial account for the value of the benefit until administration of the preventative treatment is confirmed.

The present invention relates to compositions, that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment, comprise vitamin B₆, vitamin B₉, vitamin B₁₂, calcium, vitamin D₃, magnesium, and boron, and methods for using these compositions for nutritional supplementation in order to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease, colorectal cancer and osteoporosis.

Disclosed are sustained-release medicaments/drug compositions/formulations/therapeutics for the management of pain and inflammation associated disorders in general, more particularly arthritic inflammation. The sustained-release compositions comprise effective amounts of glucosamine, curcuminoids, boswellic acids and piperine.

The present invention provides liquid formulations of SYNAGIS® or an antigen-binding fragment thereof that immunospecifically bind to a respiratory syncytial virus (RSV) antigen, which formulations exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of SYNAGIS® or an antigen-binding fragment thereof, even during long periods of storage. In particular, the present invention provides liquid formulations of SYNAGIS® or an antigen-binding fragment thereof which immunospecifically binds to a RSV antigen, which formulations are substantially free of surfactant, inorganic salts, and/or other common excipients. Furthermore, the invention provides method of preventing, treating or ameliorating symptoms associated with RSV infection utilizing liquid formulations of the present invention.

Compositions and methods for use in the therapeutic and preventative treatment, study, diagnosis and prognosis of PD-related disease are disclosed. Also provided are kits and reagents for prognosis and diagnosis of PD-related disease and related conditions.

The invention relates to acne treatment emulsion, and belongs to the field of cosmetics. The acne treatment emulsion comprises the following components: component A comprising propylene glycol, xanthan gum and first solvent; component B comprising 2-hydroxyethanesulphonic acid hexyl ether, vitamin B6 and second solvent; component C comprising plant extract, azelaic acid derivatives, dendranthema indica (L.) des moul, salicylic acid, ginseng extract, vitamin E and preservative agent. The acne treatment emulsion has the functions of treating acne, whitening and nourishing skin, moisturizing, reducing oil secretion, and promoting cellular metabolism, the effect is obvious, the action is fast, no acne scar is left after healing, and the acne is not easy to relapse; and the acne treatment emulsion is a cosmetic which is used for preventing and treating acne and whitening skin.

The invention relates to a use of angelica or an extract thereof in preparing skin care products, which belongs to a field of cosmetics. The angelica or the extract thereof have the advantages of adjusting skin secretion function, moisture keeping function, preventing and curing stains and promoting skin metabolism. The skin care products of the invention adopt the angelica or the extract thereof as main active components, which have remarkable effect on improving the complexion and healthy state of skin and provide a novel skin care selection for the public.

The invention relates to an application of dendrobium officinale, aiming at disclosing an application of a dendrobium officinale aqueous extract in preparing a medicine for preventing or treating hypertension and apoplexy. The invention also provides dipping paste, particles, capsules, tablets and oral liquid which are suitable for the novel application and are prepared by utilizing the dendrobium officinale aqueous extract and relevant preparation methods. The applied dendrobium officinale aqueous extract has a moderate and permanent function of lowering blood pressure of a white rat with hereditary apoplexy type spontaneous hypertension and can prolong the survival time thereof, enhance the survival rate and prevent apoplexy, and the relevant medicine effect function has a certain relativity with the use quantity of the dendrobium officinale aqueous extract. The dendrobium officinale aqueous extract is utilized as a medicine with a specific application, can lower the blood pressure of a patient with hypertension moderately and permanently, delays the evolution of hypertension class cerebrovascular injuries and is of great significance for human beings to prevent the hypertension and the apoplexy and lower the mutilation rate and the fatal rate of the hypertension.